natgillin/translations-raw huggingface dataset:
Prometax should not be given at the same time as other medicines with similar effects to Prometax.
Zdravila Prometax ne smete jemati sočasno z drugimi zdravili, ki imajo podobne učinke kot Prometax.
Prometax might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’ s disease or to prevent travel sickness).
Prometax bi lahko vplival na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
Pregnancy and breast-feeding It is preferable to avoid the use of Prometax during pregnancy, unless clearly necessary.
Nosečnost in dojenje Med nosečnostjo ne jemljite zdravila Prometax, razen če to ni nujno potrebno.
Women on Prometax should not breast-feed.
Ženske, ki jemljejo Prometax, ne smejo dojiti.
Prometax may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Prometax lahko povzroči vrtoglavost in zaspanost, predvsem na začetku zdravljenja ali ob povečanju odmerka.
HOW TO TAKE PROMETAX
KAKO JEMATI ZDRAVILO PROMETAX
Always take Prometax exactly as your doctor has told you.
Pri jemanju zdravila Prometax natančno upoštevajte zdravnikova navodila.
You should take Prometax twice a day with food (in the morning and evening).
Prometax morate jemati s hrano dvakrat na dan, zjutraj in zvečer.
Your doctor will tell you what dosage of Prometax to take, starting with a low dose and gradually increasing, depending on how you respond to the treatment.
Zdravnik vam bo določil odmerek zdravila Prometax, ki bo v začetku majhen in se bo postopoma povečeval, odvisno od vašega odziva na zdravljenje.
If you have not taken Prometax for several days, do not take the next dose until you have talked to your doctor.
Če zdravila Prometax več dni niste jemali, ne vzemite naslednjega odmerka, dokler se ne pogovorite s svojim zdravnikom.
Tell your caregiver that you are taking Prometax.
Povejte svojemu negovalcu, da jemljete Prometax.
If you take more Prometax than you should Tell your doctor if you find you have accidentally taken more Prometax than you are told to.
Če ste vzeli večji odmerek zdravila Prometax, kot bi smeli Če ugotovite, da ste pomotoma vzeli več zdravila Prometax, kot vam ga je zdravnik predpisal, ga o tem nemudoma obvestite.
Some people who have accidentally taken too much Prometax have experienced nausea, vomiting, diarrhoea, high blood pressure and hallucinations.
Pri nekaterih ljudeh, ki so pomotoma vzeli preveč zdravila Prometax, so se pojavili navzea (slabost s siljenjem na bruhanje), bruhanje, driska, zvišan krvni tlak in halucinacije.
If you forget to take Prometax If you find you have forgotten to take your dose of Prometax, wait and take the next dose at the usual time.
Če ste pozabili vzeti zdravilo Prometax Če ugotovite, da ste pozabili vzeti odmerek zdravila Prometax, počakajte in ob običajnem času
Like all medicines, Prometax can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo Prometax neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Additional side effects which have been reported with Prometax transdermal patches: severe confusion, anxiety, fever (common).
Pri uporabi transdermalnih obližev Prometax so dodatno opisovali še naslednje neželene učinke: hudo zmedenost, tesnobo, zvišano telesno temperaturo (pogosto).
HOW TO STORE PROMETAX
SHRANJEVANJE ZDRAVILA PROMETAX
Do not use Prometax after the expiry date which is stated on the carton.
Zdravila Prometax ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli.
120 6.
123 6.
What Prometax contains
Kaj vsebuje zdravilo Prometax – Zdravilna učinkovina je rivastigminijev hidrogentartrat. – Pomožne snovi so hipromeloza, magnezijev stearat, mikrokristalna celuloza, koloidni silicijev dioksid, želatina, rumeni železov oksid (E172), rdeči železov oksid (E172) in titanov dioksid (E171).
- The active substance is rivastigmine hydrogen tartrate.
Vsaka kapsula Prometax 1, 5 mg vsebuje 1, 5 mg rivastigmina.
Each Prometax 1.5 mg capsule contains 1.5 mg of rivastigmine.
Vsaka kapsula Prometax 3, 0 mg vsebuje 3, 0 mg rivastigmina.
Each Prometax 3.0 mg capsule contains 3.0 mg of rivastigmine.
Vsaka kapsula Prometax 4, 5 mg vsebuje 4, 5 mg rivastigmina.
Each Prometax 4.5 mg capsule contains 4.5 mg of rivastigmine.
Vsaka kapsula Prometax 6, 0 mg vsebuje 6, 0 mg rivastigmina.
What Prometax looks like and contents of the pack Prometax 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “ ENA 713 1,5 mg” on the body.
Izgled zdravila Prometax in vsebina pakiranja Prometax 1, 5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo kapsule z rdečim napisom “ ENA 713 1, 5 mg ”.
Prometax 3.0 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “ ENA 713 3 mg” on the body.
Prometax 3, 0 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo oranžen pokrovček in oranžno telo kapsule z rdečim napisom “ ENA 713 3 mg ”.
Prometax 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “ ENA 713 4,5 mg” on the body.
Prometax 4, 5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in rdeče telo kapsule z belim napisom “ ENA 713 4, 5 mg ”.
Prometax 6.0 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “ ENA 713 6 mg” on the body.
Prometax 6, 0 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rdeč pokrovček in oranžno telo kapsule z rdečim napisom “ ENA 713 6 mg ”.
This leaflet was last approved in 122 PACKAGE LEAFLET:
Navodilo je bilo odobreno
The use of Prometax in children and adolescents (age below 18 years) is not recommended.
Pri otrocih in mladostnikih (starih manj kot 18 let) uporaba zdravila Prometax ni priporočena.
123 Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
126 Jemanje drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Important information about some of the ingredients of Prometax One of the inactive ingredients in Prometax oral solution is sodium benzoate.
Pomembne informacije o nekaterih sestavinah zdravila Prometax Ena od neaktivnih sestavin peroralne raztopine Prometax je natrijev benzoat.
Using this syringe, withdraw the prescribed amount of Prometax oral solution from the container.
S to brizgo odvzemite predpisano količino peroralne raztopine Prometax iz vsebnika.
Each dose of Prometax oral solution may be swallowed directly from the syringe.
Vsak odmerek peroralne raztopine Prometax lahko pogoltnete neposredno iz brizge.
Some people who have accidentally taken too much Prometax have experienced nausea, vomiting, diarrhoea, high blood pressure and hallucinations.
127 pomotoma vzeli preveč zdravila Prometax, so se pojavili navzea (slabost s siljenjem na bruhanje), bruhanje, driska, zvišan krvni tlak in halucinacije.
Slow heart beat and
Lahko se pojavita tudi upočasnjen srčni utrip in omedlevica.
If you forget to take Prometax If you find you have forgotten to take your dose of Prometax, wait and take the next dose at the usual time.
Če ste pozabili vzeti zdravilo Prometax Če ugotovite, da ste pozabili vzeti odmerek zdravila Prometax, počakajte in ob običajnem času vzemite naslednji odmerek.
Do not store above 30°C.
128 Shranjujte pri temperaturi do 30 °C.
125 Use Prometax oral solution within 1 month of opening the bottle.
Peroralno raztopino Prometax porabite v 1 mesecu po prvem odprtju steklenice.
- The active substance is rivastigmine hydrogen tartrate.
Kaj vsebuje zdravilo Prometax – Zdravilna učinkovina je rivastigminijev hidrogentartrat.
What Prometax looks like and contents of the pack Prometax oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug.
Izgled zdravila Prometax in vsebina pakiranja Peroralna raztopina Prometax je na voljo v obliki 50 ml ali 120 ml bistre rumene raztopine (2, 0 mg/ ml baze), v jantarno obarvani steklenici z za otroke varno zaporko, oblogo iz penaste gume, s kapalnim vložkom in s prilegajočim se zamaškom.
Eesti Novartis Pharma Services Inc.
129 Eesti Österreich Novartis Pharma Services Inc.
Prometax oral solution
130 Navodila za uporabo peroralne raztopine Prometax
Withdraw prescribed amount of Prometax oral solution from bottle.
Iz steklenice potegnite predpisano količino peroralne raztopine Prometax.
Swallow Prometax oral solution directly from the syringe or first mix in a small glass with water.
Peroralno raztopino Prometax pogoltnite naravnost iz brizgalke ali pa jo prej v majhnem kozarcu zmešajte z vodo.
Prometax 4.6 mg/ 24 h transdermal patch Prometax 9.5 mg/ 24 h transdermal patch rivastigmine
Prometax 4, 6 mg/ 24 h transdermalni obliž Prometax 9, 5 mg/ 24 h transdermalni obliž rivastigmin
Before you use Prometax 3.
Kaj morate vedeti, preden boste uporabili zdravilo Prometax 3.
How to use Prometax 4.
Kako uporabljati zdravilo Prometax 4.
Prometax is used for the treatment of memory disorders in patients with Alzheimer’ s disease.
Zdravilo Prometax uporabljamo za zdravljenje spominskih motenj pri bolnikih z Alzheimerjevo boleznijo.
BEFORE YOU USE PROMETAX
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO PROMETAX
Do not use Prometax
Ne uporabljajte zdravila Prometax
- if you are allergic (hypersensitive) to rivastigmine (the active substance in Prometax) or to any
- če ste alergični na (preobčutljivi za) rivastigmin (zdravilno učinkovino v zdravilu Prometax) ali
of the other ingredients listed in section 6 of this leaflet.
katerokoli sestavino zdravila, ki je navedena v poglavju 6 tega navodila za uporabo,
- if you have, or have ever had, difficulties in passing urine.
če imate ali če ste kdaj imeli težave z uriniranjem,
The use of Prometax in children and adolescents (age below 18 years) is not recommended.
133 Pri otrocih in mladostnikih (starih manj kot 18 let) uporaba zdravila Prometax ni priporočena.
Prometax might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson’ s disease or to prevent travel sickness).
Zdravilo Prometax lahko vpliva na antiholinergična zdravila (zdravila. ki se uporabljajo za lajšanje želodčnih krčev, za zdravljenje Parkinsonove bolezni ali za preprečevanje potovalne slabosti) oziroma ta zdravila lahko vplivajo na rivastigmin.
Using Prometax with food and drink Food or drink do not affect the use of Prometax transdermal patches because rivastigmine enters the bloodstream through the skin.
Uporaba zdravila Prometax skupaj s hrano in pijačo Uživanje hrane in pijače ne vpliva na uporabo transdermalnih obližev Prometax, ker rivastigmin prehaja v krvni obtok skozi kožo.
If you are pregnant, the benefits of using Prometax transdermal patches must be assessed against the possible effects on your unborn child.
V primeru, da ste noseči, je treba pretehtati koristi uporabe transdermalnih obližev Prometax in možne učinke na nerojenega otroka.
HOW TO USE PROMETAX
KAKO UPORABLJATI ZDRAVILO PROMETAX
Always use Prometax transdermal patches exactly as your doctor has told you.
Pri uporabi transdermalnih obližev Prometax natančno upoštevajte zdravnikova navodila.
Only wear one Prometax patch at a time.
Nosite samo en obliž Prometax naenkrat.
How to start treatment Your doctor will tell you which Prometax transdermal patch is most suitable for you. • Treatment usually starts with Prometax 4.6 mg/ 24 h. • The usual daily dose is Prometax 9.5 mg/ 24 h. • Only one transdermal patch should be worn at a time and the transdermal patch should be replaced by a new one after 24 hours.
Transdermalni obliž je treba po 24 urah zamenjati z novim.
131 Where to apply Prometax transdermal patches
134 Kam namestiti transdermalne obliže Prometax
How to apply Prometax transdermal patches Prometax patches are thin, opaque, plastic patches that stick to the skin.
Kako namestiti transdermalni obliž Prometax Obliži Prometax so tanki neprozorni plastični obliži, ki jih prilepite na kožo.
132 The patch should be worn continuously until it is time to replace it with a new one.
135 Obliž morate nositi neprekinjeno, dokler ga ne zamenjate z novim.
How to remove Prometax transdermal patches Gently pull at one edge of the patch to remove it completely from the skin.
Kako odstraniti transdermalne obliže Prometax Nežno povlecite za en rob obliža in nato obliž odstranite v celoti.
How to dispose of Prometax transdermal patches After removing a patch, fold it in half with the sticky sides on the inside and press them together.
Kako zavreči transdermalne obliže Prometax Po odstranitvi obliža s kože ga prepognite na pol z lepljivo stranjo navznoter in stisnite.
Otherwise, return used patches to a pharmacy, preferably in the original packaging.
Se sme transdermalne obliže Prometax nositi med kopanjem in plavanjem ter na soncu?
Can you wear Prometax transdermal patches when you are bathing, swimming, or in the sun? • Bathing, swimming or showering should not affect the patch.
Preverite, da med temi dejavnostmi
When and for how long to apply Prometax transdermal patches To benefit from treatment, you must apply a new patch every day, preferably at the same time of day.
Kdaj namestiti transdermalne obliže Prometax in za koliko časa Da bi vam zdravljenje koristilo, morate obliž zamenjati vsak dan, če se le da vsak dan ob istem času.
If you use more Prometax than you should If you accidentally apply more than one patch, remove all the patches from your skin, then inform your doctor that you have accidentally applied more than one patch.
Če ste uporabili večji odmerek zdravila Prometax, kot bi smeli Če ste nehote namestili več kot en obliž, odstranite s kože vse obliže in obvestite zdravnika, da ste nehote namestili več kot en obliž.
If you forget to use Prometax If you find you have forgotten to apply a patch, apply one immediately.
Če ste pozabili uporabiti zdravilo Prometax Če ugotovite, da ste pozabili namestiti obliž, ga takoj namestite.
If you have not applied an Prometax patch for several days, do not apply the next one until you have talked to your doctor.
Če obliža Prometax niste namestili več dni, ne nameščajte naslednjega, dokler se ne pogovorite s svojim zdravnikom.
133 effects (less than 1 in 10 patients but more than 1 in 100 patients).
136 bruhanje sta pogosta neželena učinka (pri manj kot 1 od 10 bolnikov, a pri več kot 1 od 100 bolnikov).
Additional side effects which have been reported with Prometax capsules or oral solution are:
Dodatni neželeni učinki, o katerih so poročali pri kapsulah ali peroralni raztopini Prometax:
The expiry
- Zdravila Prometax ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na
date refers to the last day of the month.
Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
What Prometax contains
Kaj vsebuje zdravilo Prometax
Each patch releases 4.6 mg of rivastigmine per 24 hours is 5 cm2 and contains 9 mg of rivastigmine.
Prometax 4, 6 mg/ 24 h transdermalni obliži: vsak obliž sprosti 4, 6 mg rivastigmina na 24 ur, je velik 5 cm2 in vsebuje 9 mg rivastigmina.
Each patch releases 9.5 mg of rivastigmine per 24 hours is 10 cm2 and contains 18 mg of rivastigmine.
Prometax 9, 5 mg/ 24 h transdermalni obliži: vsak obliž sprosti 9, 5 mg rivastigmina na 24 ur, je velik 10 cm2 in vsebuje 18 mg rivastigmina.
What Prometax looks like and contents of the pack Each transdermal patch is a thin patch consisting of three layers.
Izgled zdravila Prometax in vsebina pakiranja Vsak transdermalni obliž je tanek obliž, sestavljen iz treh plasti.
- “ Prometax”, “ 4.6 mg/ 24 h” and “ AMCX”,
- “ Prometax ”, “ 4, 6 mg/ 24 h ” in “ AMCX ”,
- “ Prometax”, “ 9.5 mg/ 24 h” and “ BHDI”.
- “ Prometax ”, “ 9, 5 mg/ 24 h ” in “ BHDI ”.
France Novartis Pharma S. A. S.
138 France Novartis Pharma S. A. S.
ProQuad is a vaccine against measles, mumps, rubella, and varicella (chickenpox).
Zdravilo Zdravilo ProQuad je cepivo proti ošpicam, mumpsu, rdečkam in noricam.
ProQuad is a suspension given by subcutaneous injection (injection under the skin).
Cepivo ProQuad je suspenzija, ki se daje s subkutano injekcijo (injiciranjem pod kožo).
The active substances are attenuated (weakened) viruses for the diseases.
Zdravilne učinkovine so atenuirani (oslabljeni) virusi bolezni.
ProQuad is given to children from 12 months of age to help protect them from the four diseases: measles, mumps, rubella, and varicella (chickenpox).
Cepivo ProQuad se daje otrokom od starosti 12 mesecev dalje z namenom zaščite proti naslednjim štirim boleznim: ošpicam, mumpsu, rdečkam in noricam.
ProQuad is provided as two separate components: a powder that must be kept frozen, and a solvent, in a vial or pre-filled syringe, that is kept in a refrigerator or at room temperature.
Zdravilo ProQuad se dobavlja v obliki dveh ločenih komponent: praška, ki ga je treba hraniti v zamrznjenem stanju, in vehikla v viali ali predhodno napolnjeni brizgi, ki ga hranimo v hladilniku ali pri sobni temperaturi.
Immediately before administration, the doctor or nurse will need to make up the suspension for injection by dissolving the frozen powder with the solvent.
Tik pred uporabo bosta zdravnik ali medicinska sestra naredila suspenzijo za injiciranje tako, da bosta raztopila zmrznjen prašek v vehiklu.
In order to protect against varicella (chickenpox), two doses of the weakened varicella virus are needed; this can be done either by giving two doses of ProQuad, or by giving a single dose of ProQuad followed by a dose of another vaccine that only protects against varicella.
Za zaščito proti noricam sta potrebna dva odmerka oslabljenega virusa noric; to lahko izvedemo tako, da injiciramo bodisi dva odmerka zdravila ProQuad ali pa en odmerek zdravila ProQuad, ki mu sledi odmerek drugega cepiva, ki nudi zaščito samo proti noricam.
The second dose in both cases is given between one and three months after the first one.
Drugi odmerek se v obeh primerih daje eden mesec do tri mesece po prvem odmerku.
ProQuad contains weakened forms of the viruses that cause measles, mumps, rubella, and chickenpox.
Cepivo ProQuad vsebuje oslabljene viruse, ki povzročajo ošpice, mumps, rdečke in norice.
When a person is given the vaccine, the immune system recognises the weakened viruses as ‘ foreign’ and makes antibodies against them.
Ko oseba prejme odmerek cepiva, imunski sistem prepozna oslabljene viruse kot tujke in proti njim razvije protitelesa.
In the future, the immune system will be able to produce antibodies quicker when it is again exposed to the viruses.
Ko bo imunski sistem naslednjič izpostavljen virusom, bo lahko hitreje izdelal protitelesa.
The antibodies will help to protect against diseases caused by these viruses.
Ta mu bodo pomagala pri obrambi pred boleznimi, ki jih ti virusi povzročajo.
ProQuad contains well known weakened viruses, which are already used in other vaccines.
Zdravilo ProQuad vsebuje dobro znane oslabljene viruse, ki se že uporabljajo v drugih cepivih.
The studies measured the
Pri preučevanju zdravila ProQuad pri ljudeh so ga primerjali s cepivi, ki so komponente cepiva ProQuad, t. j. trojnim cepivom proti mumpsu, ošpicam in rdečkam ter cepivom proti noricam.
7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
Cepivo so preučevali pri 5. 446 zdravih otrocih (starih od 12 do 23 mesecev), ki so prejeli en odmerek cepiva 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. eu. int http: / /www. emea. eu. int  EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged ‘ immunogenicity’ of the vaccine (its ability to make the immune system respond to the viruses).
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. eu. int http: // www. emea. eu. int EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged ProQuad.
A study also looked at the responses one year after vaccination in 2,108 children.
V raziskavah so merili » imunogenost « cepiva (njegovo sposobnost, da vzbudi odziv imunskega sistema).
What benefit has ProQuad shown during the studies?
Kakšne koristi je zdravilo ProQuad izkazalo med raziskavami?
The response rates (measuring how the immune system had responded to the viruses) were:
Stopnje odziva (ki merijo, kako se imunski sistem odzove na viruse) so bile:
97.4% for measles, 95.8% to 98.8% for mumps, 98.5% for rubella and 91.2% for varicella.
97, 4% pri ošpicah, od 95, 8% do 98, 8% pri mumpsu, 98, 5% pri rdečkah in 91, 2% pri noricah.
After the second dose, the rates were 99.4% for measles, 99.9% for mumps, 98.3% for rubella, and 99.4% for varicella.
Po drugem odmerku so bile stopnje odziva 99, 4% pri ošpicah, 99, 9% pri mumpsu, 98, 3% pri rdečkah in 99, 4% pri noricah.
The most common side-effect in the studies was fever (more than 1 child in 10).
Najpogostejši neželeni stranski učinek, opažen v raziskavah, je bila povišana telesna temperatura (pri več kot 1 izmed 10 otrok).
For the full list of all side effects reported with ProQuad, see the Package Leaflet.
Celovit opis neželenih stranskih učinkov, o katerih so poročali pri uporabi cepiva ProQuad, najdete v Navodilih za uporabo.
Children should not be vaccinated with ProQuad if they have an allergy to any varicella vaccine or measles, mumps, or rubella vaccine, to any of the excipients, or to neomycin, or if they have any disease that affects their immune system.
Otroci ne smejo biti cepljeni s cepivom ProQuad, če so alergični na katerokoli cepivo proti noricam ali cepivo proti ošpicam, mumpsu ali rdečkam, na katerekoli pomožno snov ali na neomicin, ali če imajo katerokoli bolezen, ki slabi njihov imunski sistem.
The Committee for Medicinal Products for Human Use (CHMP) decided that ProQuad’ s benefits are greater than its risks in the simultaneous vaccination against measles, mumps, rubella and varicella of individuals from 12 months of age.
Odbor za zdravila za uporabo v humani medicini (CHMP) je odločil, da so koristi zdravila ProQuad pri sočasnem cepljenju posameznikov, starejših od 12 mesecev, proti ošpicam, mumpsu, rdečkam in noricam večje od z njim povezanih tveganj.
They recommended that ProQuad be given a marketing authorisation.
Zato je priporočil, da se za cepivo ProQuad odobri dovoljenje za promet z zdravilom.
They also recommended that a second dose of vaccination against varicella (chickenpox) should be given to complete protection against the disease.
Prav tako je priporočil, da je za popolno zaščito proti noricam potreben drugi odmerek cepiva proti tej bolezni.
Other information about ProQuad:
Druge informacije o zdravilu ProQuad:
The European Commission granted a marketing authorisation valid throughout the European Union to Sanofi Pasteur MSD SNC on 6 April 2006.
Evropska komisija je dovoljenje za promet z zdravilom ProQuad, veljavno po vsej Evropski uniji, odobrila družbi Sanofi Pasteur MSD SNC dne 6. aprila 2006.
The full EPAR for ProQuad is available here.
Celotno Evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo ProQuad je na voljo tukaj.
This summary was last updated in 04-2006
Ta povzetek je bil nazadnje posodobljen 04- 2006.
Strength Pharmaceutical Form §
Jakost §
powder: vial (glass); solvent:
prašek: viala (steklo); vehikel: viala (steklo)
10 vials + 10 vials
10 vial +10 vial
powder: vial (glass); solvent:
prašek: viala (steklo); vehikel: napolnjena brizga (steklo)
1 vial + 1 pre-filled syringe with attached needle
1 viala +1 napolnjena brizga z nameščeno iglo
10 vials + 10 pre-filled syringes with attached needle
10 vial +10 napolnjenih brizg z nameščeno iglo
1 vial + 1 pre-filled syringe without needle
1 viala +1 napolnjena brizga brez igle